Stocktoria

AYTU BIOPHARMA, INC AYTU

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2017-10-20

AYTU BIOPHARMA, INC statistics & valuation

Market cap$23.3M
P / S0.4×
P / B0.7×
P / FCF7.2×
Net margin-24.8%
Return on equity-40.4%
FCF margin5.6%
Net cash$17.2M
Enterprise value USD$6.1M
Earnings yield EBIT/EV-136.7%
Return on capital-16.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-698.70% -278.30% -370.60% -49.30% -88.80% -112.50% -15.90% -24.30% -20.40% -24.80% 2017201820192020202120222023202420252026
Gross margin (%)
70.00% 44.50% 54.10% 62.00% 75.30% 69.00% 64.00% 2017201820192020202120222023202420252026
Operating margin (%)
-624.70% -538.20% -230.10% -76.50% -89.70% -113.70% -15.90% -2.40% -11.80% -14.40% 2017201820192020202120222023202420252026
Return on equity (%)
-562.70% -75.90% -382.80% -14.30% -42.40% -245.50% -43.30% -57.20% -71.50% -40.40% 2017201820192020202120222023202420252026
Shares outstanding
41244 1.8M 17.5M 12.6M 27.5M 1.9M 5.5M 6.0M 9.0M 12.3M 2017201820192020202120222023202420252026
Net debt ($)
-$7.0M -$11.0M -$4.4M -$8.0M -$9.1M -$20.1M -$17.2M 2017201820192020202120222023202420252026
Share buybacks ($)
2017201820192020202120222023202420252026
Return on assets (%)
-150.10% -48.40% -78.10% -8.90% -21.90% -79.00% -12.50% -13.40% -10.90% -13.60% 2017201820192020202120222023202420252026
Free cash flow margin (%)
-432.70% -437.60% -189.80% -102.70% -2.60% -3.30% 5.60% 2017201820192020202120222023202420252026
Debt / equity (×)
0.00× 0.00× 0.34× 0.38× 0.39× 0.57× 0.26× 2017201820192020202120222023202420252026
EPS ($)
-$3.48 -$74.01 -$5.11 2017201820192020202120222023202420252026

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Gross margin64.0%69.0%75.3%62.0%54.1%44.5%70.0%———
Operating margin-14.4%-11.8%-2.4%-15.9%-113.7%-89.7%-76.5%-230.1%-538.2%-624.7%
Net margin-24.8%-20.4%-24.3%-15.9%-112.5%-88.8%-49.3%-370.6%-278.3%-698.7%
FCF margin5.6%-3.3%-2.6%———-102.7%-189.8%-437.6%-432.7%
Return on assets-13.6%-10.9%-13.4%-12.5%-79.0%-21.9%-8.9%-78.1%-48.4%-150.1%
Return on equity-40.4%-71.5%-57.2%-43.3%-245.5%-42.4%-14.3%-382.8%-75.9%-562.7%
Debt / equity0.26×0.57×0.39×0.38×0.34×——0.00×0.00×—
Current ratio1.131.260.991.060.930.962.622.872.790.84

Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.